Editor's Highlight: PPARβ/δ and PPARγ Inhibit Melanoma Tumorigenicity by Modulating Inflammation and Apoptosis

Area of Science:

• Molecular biology
• Oncology
• Dermatology

Background:

• Skin tumorigenesis involves DNA damage, inflammation, and apoptosis evasion.
• Peroxisome proliferator-activated receptors (PPARs) influence non-melanoma skin cancer mechanisms.
• Limited data exists on PPARs' role in melanoma.

Purpose of the Study:

• To investigate the effects of PPARβ/δ and PPARγ on melanoma cell behavior.
• To assess the impact of PPARs on cell proliferation, clonogenicity, and xenograft growth in a human melanoma cell line.

Main Methods:

• Stable overexpression of PPARβ/δ or PPARγ in UACC903 melanoma cells.
• Analysis of cell cycle distribution, proliferation, and anchorage-dependent clonogenicity.
• Evaluation of ectopic xenograft tumor formation and apoptosis induction.

Main Results:

• Overexpression of PPARβ/δ or PPARγ enhanced target gene expression and altered cell cycle phases (G1/S reduction, G2/M increase).
• Ligand activation of PPARγ further enhanced cell cycle changes; PPARβ/δ ligand activation had no additional effect.
• Both PPARβ/δ and PPARγ, with or without ligand activation, inhibited cell proliferation, clonogenicity, and xenograft tumorigenicity, partly via apoptosis induction.

Conclusions:

• PPARβ/δ and PPARγ exhibit antitumorigenic effects in melanoma.
• Targeting PPARβ/δ and PPARγ may offer a strategy for melanoma chemoprevention.